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1. Introduction 
It has been reported previously (i) that N6 ,O*'-di- 
butyryl cyclic adenosine 3’,5’-monophosphate 
(DBcAMP) as well as hydrocortisone stimulate the de 
novo synthesis of tyrosine aminotransferase (TAT, EC 
2.6.1.5) [ 1,2] and phosphoenolpyruvate carboxykinase 
(PEP-CK, EC 4.1.1.32) [3] in adult rat liver, (ii) that 
the stimulation by DBcAMP of both enzymes was re- 
duced by adrenalectomy [4] and (iii) that combined 
application of DBcAMP and glucocorticoids produced 
additive and sometimes synergistic effects in vivo [l] 
and in organ culture [5,6]. From the latter two findings 
the suggestion has been made that the system involved 
in the regulation of the de novo synthesis of these 
enzymes is rendered more ‘sensitive’ to CAMP by glu- 
cocorticoids. In contrast to this suggestion the present 
study supports the view that DBcAMP elevates both 
enzymes by a mechanism, which, in principle, works 
independently from glucocorticoids while glucocorti- 
coids stimulate a different process, which is required 
for the maintenance of the CAMP-mediated enzyme in- 
duction. 
2. Materials and methods 
Male Wistar rats, purchased from E. Jautz, Kiss- 
legg/Allgau, weighing 200 g, were used. Intact animals 
were kept on a low protein diet (Altromin GmbH, 
Lage/Lippe, C 1004) for 6 days before the experiments. 
Adrenalectomized rats, receiving 0.9% NaCl solution 
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to drink, were fed a standard chow diet for 4 days and, 
thereafter, a low protein diet for 6 days. In the begin- 
ning of the experiments (8.00 a.m.) food was withdrawn. 
DBcAMP, theophylline, hydrocortisone and NaCl solu- 
tions were injected as indicated in the legend of fig. 1. 
Rats were killed by decapitation and the livers were 
homogenized in 7 vol of ice-cold 0.15 M KC1 in a 
Potter-Elvejham homogenizer fitted with a Teflon 
pestle at 1000 rpm for 30 sec. The homogenate was 
centrifuged for 30 min at 150 000 g at 0°C and 
PEP-CK activity was immediately assayed in the super- 
natant according to Seubert and Huth [7]. Enzyme 
activity (U) is expressed as pmoles oxaloacetate con- 
verted to phosphoenolpyruvate per min at 37’C under 
the conditions of the assay. TAT activity was deter- 
mined in the supernatant 24 hr later according to 
Diamandstone [8], using a modification based on the 
data of Wurtmann and Lavi [9]. One unit of the en- 
zyme activity is defined as the amount of enzyme re- 
quired to form 1 pmole of p-hydroxyphenylpyruvate 
per min at 37°C under the conditions of the assay. 
Protein was assayed by the biuret method [lo]. CAMP 
was estimated according to Gilman [l 1] after total 
alkaline hydrolysis of DBcAMP in 0.1 N NaOH at 
70°C for 45 min [ 12 1. Glycogen was determined 
enzymatically, after decomposition of the tissue in 4 N 
KOH and hydrolysis with 4 N HCl, by the method of 
Slein [ 131. Glucose was measured according to Schmidt 
[ 141. The significance of differences between means was 
established by the student t test. Substrates, nucleo- 
tides and coupling enzymes were purchased from 
Boehringer, Mannheim. Hydrocortisone (cristal sus- 
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Fig. 1. Time course of effects of dibutyryl cyclic AMP and/or hydrocortisone on hepatic tyrosine aminotransferase (TAT) and 
PEP carboxykinase (PEP-CK) activities of intact and adrenalectomized rats. DBcAMP (20 mg/kg) + theophylline (20 mg/kg) was 
injected intraperitoneally at zero time and again every 90 min. Hydrocortisone (25 mg/kg) was injected at zero time followed by 
further application of0.9% NaCl every 90 min. Two groups of controls were performed, one without injection, the other injected with 
0.9% NaCl every 90 min. For both control groups, n = 6; for hydrocortisone, n = 6-8; for DBcAMP and DBcAMP + hydrocorti- 
sone, n = 8- 11. Values are given as means f SEM. SEM was determined for all data points, but in several cases the brackets were 
too small to be conveniently included in the drawing. Statistical analysis TAT: Intact: AU hormone or DBcAMP values versus NaCl 
controls: p < 0.0005. Adrenalectomy: All hydrocortisone values versus NaQ controls;p < 0.0005. DBcAMP, 2,4 and 6 hr versus 
NaCl controls: p < 0.0005, p < 0.005 and non significant (= n.s.). Statistical analysis PEP-CK: Intact: All DBcAMP and DBcAMP 
+ hydrocortisone values versus NaCl controls: p < 0.0005. Hydrocortisone, 2 hr versus NaCl control: p < 0.025. NaCl controls, 
2,4 and 6 hr versus ‘without injection’: n.s., p < 0.005 and p < 0.0025. Adrenalectomy: DBcAMP + hydrocortis&re, 2,4 and 6 
hr versus NaCl controls: p < 0.0005. DBcAMP, 2,4 and 6 hr versus NaCl controls: p < 0.0005, p < 0.0005 and p‘< 0.005. 
Hydrocortisone, 2,4 and 6 hr versus NaCl controls: p < 0.05, p < 0.025 and p < 0.025. NaCl controls, 2, 4 and 6 hr versus 
‘without injection’: p < 0.05, n.s. and p < 0.01. 159 
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pension, 25 mg/ml) was obtained from Hoechst AC, 
Frankfurt/Main-Hoechst. 
In our experiments DBcAMP was always injected 
in combination with theophylline. Moreover, we have 
determined that the decline of TAT and PEP-CK 
3. Results 
The time courses of effects of DBcAMP, hydrocorti-. 
sane and DBcAMP + hydrocortisone on hepatic TAT 
and PEP-CK activities of intact and adrenalectomized 
rats are shown in fig. 1. 
A single injection of hydrocortisone into intact 
rats fed a low protein diet elevated TAT activity 
following DBcAMP injection into adrenalectomized rats 
was not the result of an enhanced degradation of the 
cyclic nucleotide. At the end of the experiments the 
concentration of total CAMP in the blood plasma was 
approximately the same in DBcAMP injected (2.2 + 1.5 
nmoles/ 100 ml (n=6) and in DBcAMP + hydrocorti- 
sone injected (1.9 t 1.2 nmoles/lOO ml (n=6)) 
adrenalectomized rats. 
alone, but was more effective at 4 hr (p < 0.0005). 
In adrenalectomized rats hydrocortisone elicited 
almost the same degree of elevation of TAT activity 
as in intact animals. Also, DBcAMP initially produced 
the same respone as in intact rats. However, after 2 hr 
the increase of TAT due to DBcAMP ceased completely 
and enzyme level fell at a rate approximating the known 
rate of degradation of this enzyme (t f = 90 min) [ 151. 
Restoration of hydrocortisone to the adrenalectomized 
rats completely restored the DBcAMP effect which was 
observed with intact animals. 
linearly up to 6 hr. About twice this increase occurred 
when DBcAMP was injected repeatedly every 90 min. 
The combination of DBcAMP and hydrocortisone pro- 
duced no greater response at 2 and 6 hr than did DBcAMP 
expected time course of TAT and PEP-CK activity 
after repeated injections of maximal doses of DBcAMP 
into adrenalectomized rats: in the early phase of the 
experiments both enzymes were stimulated to the 
same degree as in intact animals, but, beyond 2 hr, 
their activity returned towards control values. 
4. Riscussion 
The essential finding of the present study is the un- 
These findings might be discussed in view of the 
hypothesis of Wicks based on the results of studies 
on fetal rat liver in organ culture and cultured hepatoma 
cells (for review see ref. [4,19]): Hydrocortisone pro- 
motes an increase in the level of TAT and PEP-CK 
templates and CAMP enhances the expression of pre- 
existing templates. Applying this concept to our re- 
sults we suggest hat adrenalectomy limits the amount 
of translatable templates by limiting either its synthesis 
[20] or by enhancing its degradation [2 1 ] and, there- 
fore, DBcAMP could stimulate enzyme induction 
only until preexisting templates were exhausted. 
Essentially the same results were obtained for PEP- 
CK in intact and adrenalectomized rats. However, there 
were some differences to be noted in comparison with 
TAT. (i) PEP-CK activity increased slightly in the non 
injected controls. This did not represent the circadian 
rhythm of the enzyme, which is virtually absent in 
rats on a protein-free diet [ 16,171, but was probably 
caused by the beginning of starvation, as could be con- 
cluded from the significant decrease of liver glycogen 
levels. (ii) The repeated injection of NaCl elicited a 
considerable elevation of PEP-CK activity. Since enzyme 
activity rose in adrenalectomized rats as well and since 
glycogen levels were effectively depleted after NaCl 
injection, compared with the non injected controls, the 
phenomenon might be attributed to a catecholamine 
mediated elevation of endogenous CAMP. (iii) In 
adrenalectomized animals enzyme activity after 
DBcAMP injection declined after 2 hr less rapidly than 
did TAT. The smaller rate of decline might be ascribed 
to the considerably longer half-life of PEP-CK, which 
has been estimated as 5-6 hr by Shrago et al. [ 181. 
160 
If so, inhibitors of transcription would be expected 
to prevent de novo synthesis of TAT and PEP-CK in- 
duced by glucocorticoids but to be without effect in 
the early phase of CAMP-mediated enzyme induction. 
In fact, this has been reported for cultured Reuber 
H35 hepatoma cells. Actinomycin D completely blocked 
the response of PEP-CK to dexamethasone, but did not 
suppress the early increase of the enzyme after addition 
of DBcAMP [22]. Similarly, in Reuber hepatoma 
(H-4-11-E) cells, actinomycin D at a dose sufficient 
to inhibit RNA synthesis 95%, did not alter the ele- 
vation of TAT activity in the presence of DBcAMP [23]. 
In adrenalectomized rats, the inhibitory effect of 
actinomycin D on the hydrocortisone-induced stimula- 
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tion of hepatic TAT [24] and PEP-CK [25] has been 
confirmed. However, conflicting results have been ob- 
tained with DBcAMP in vivo. On one hand actinomicin- 
D was reported to be without effect on the increase of 
hepatic TAT provoked by DBcAMP injection into neo- 
natal rats [26], and S-azacytidine, which is believed to 
promote the synthesis of defective mRNA, did not 
inhibit the CAMP-mediated induction of TAT in the 
liver of adrenalectomized rats [27]. Contrary to this, 
other workers found pretreatment of adrenalectomized 
rats with actinomycin D to considerably inhibit [28] 
or even totally block [29] the increase of TAT after 
glucagon or DBcAMP injection respectively. At this 
time, therefore, it cannot be excluded that CAMP may 
regulate the synthesis of TAT and PEP-CK also at the 
transcriptional level. 
Whatever the exact mechanism of interaction be- 
tween glucocorticoids and CAMP in hepatic enzyme 
synthesis might be, two conclusions can be drawn from 
our results: (1) DBcAMP can induce TAT and PEP-CK 
by a mechanism, which, in principle, works indepen- 
dently of glucocorticoids. (2) The maintenance of 
DBcAMP-mediated induction of both enzymes requires 
a process, which is stimulated by glucocorticoids. 
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